Institutional investors debate pandemic's medium-term impact on allocations but agree risk will reign supreme for the next 12 to 18 months.
Special Reports
COVID-19: One year in
P&I's staff spoke to the experts about what they've learned in the year since the pandemic changed everything.
FEATURE STORIES
The pandemic has boosted investor interest in pharmaceuticals but not all subsectors.
Asset owners and managers shifted seamlessly to remote working/due diligence but challenges in the new environment remain to be addressed.
Logistics is standing out as a resilient investment during a global pandemic.
Blackstone is building a real estate and private equity investment "ecosystem" around the life sciences sector.
MULTIMEDIA
In the span of a year, the coronavirus pandemic has changed almost everything. This is a look at its spread and impact on the S&P 500.
What change in money management work practices do you expect will last after the pandemic is over?
EDITORIAL
The continuum of uncertainty launched by the coronavirus pandemic is ongoing, even as managers and investors recalibrate.
Sponsored
White Papers
Sponsored Content
Partner Content